RNA Drug Breakthrough for Lupus Patients
Researchers in Victoria have developed a groundbreaking RNA drug to prevent the damaging effects of lupus, a significant advancement in the treatment of autoimmune diseases.
Lupus is a chronic autoimmune disease that causes the immune system to attack healthy cells, resulting in joint pain, fatigue, skin problems, and inflammation of organs. Approximately 90% of sufferers are women, often during their reproductive years, impacting fertility and pregnancy.
- The innovation is being trialled at the Hudson Institute of Medical Research in Clayton through Australian biotech company Noxopharm.
- The Labor Government invested $100,000 in the project through the mRNA Victoria Research Acceleration Fund in 2022.
No specific quote available in the given text.
Author's summary: RNA drug offers hope for lupus patients.
More News
- Zohran Mamdani wins NYC mayor’s race, capping a stunning ascent
- Pentagon Concedes Russian Threat as Trump-Era Policy Shop Faces Revolt in Senate Hearing
- Zohran Mamdani Becomes New York City’s First Muslim Mayor
- McPhaul edges out Kerr for Gainesville school board seat
- Elliott wins Gainesville City Council Ward 2 seat
- Prop 50 could hand Garcia a MAGA stronghold
- The story LI's election numbers tell so far
- Wanda Williams wins mayoral re-election after Dan Miller concedes race